The mutation is accompanied by the onset of increased cytokine production, pro-inflammatory leukocytes, and elevated expression levels of MMPs-all of which drive elastin degradation and are classically associated with thoracic aortic aneurysm development. The gene discussed is ELN; the disease is thoracic aortic aneurysm.